Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors

Gene Therapy

Volumn 3, Issue 1, 1996, Pages 75-84

  Imler, J L ^a,b   Chartier, C ^a   Dreyer, D ^a   Dieterle A ^a   Sainte Marie, M ^a   Faure, T ^a   Pavirani, A ^a   Mehtali, M ^a  

^a TRANSGENE S A   (France)

^b CNRS   (France)

Author keywords

293; A549; adenovirus; E1 complementation; RCA

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CANCER CELL; CELL LINE; CONTROLLED STUDY; GENE THERAPY; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; LUNG CARCINOMA; PRIORITY JOURNAL; VIROGENESIS;

ADENOVIRUS E1 PROTEINS; ADENOVIRUS E1A PROTEINS; ADENOVIRUS E1B PROTEINS; ADENOVIRUSES, HUMAN; ANIMALS; CAPSID; CAPSID PROTEINS; CARCINOMA; CERCOPITHECUS AETHIOPS; GENE EXPRESSION; GENE EXPRESSION REGULATION, VIRAL; GENETIC COMPLEMENTATION TEST; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; PLASMIDS; TRANSFECTION; TUMOR CELLS, CULTURED; VERO CELLS;

EID: 0029962803     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Graham FL, Prevec L. Adenovirus based expression vectors and recombinant vaccines. In: Ellis RW (ed). Vaccines: New Approaches to Immunological Problems. Butterworth-Heinemann: Stoneham, 1992, pp 363-390.
2. Trapnell BC. Adenoviral vectors for gene transfer. Adv Drug Deliv Rev 1993; 12: 185-199
3. Imler JL. Adenovirus vectors as recombinant viral vaccines. Vaccine 1995; 13: 1143-1151.
4. Chroboczek J, Bieber F, Jacrot B. The sequence of the adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 1992; 186: 280-285.
5. Horwitz MS. Adenoviridae and their replication. In: Fields BN, Knipe DM et al (eds). Virology. Raven Press: New York, 1990, pp 1679-1721.
6. Liu F, Green MR. Promoter targeting by adenovirus E1A through interaction with different cellular DNA binding domains. Nature 1994; 368: 520-525.
7. Graham FL Transformation by and oncogenicity of human adenoviruses. In: Ginsberg HS (ed). The Adenovirus. Plenum Press: New York, 1984, pp 339-398.
8. Whyte P, Buchkovich KJ, Horowitz et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product Nature 1988; 334: 124-129.
9. White E, Capriani R. Specific disruption of intermediate filaments and the nuclear lamina by the 19-kDa product of the adenovirus E1B oncogene. Proc Natl Acad Sci USA 1989; 86: 9886-9890.
10. White E, Sabbatini P, Debbas M et al. The 19 kDa adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α. Mol Cell Biol 1992; 12: 2570-2580.
11. Rao L, Debbas M, Sabbarini P et al. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19 kDa and Bcl-2 proteins. Proc Natl Acad Sci USA 1992; 89: 7742-7746.
12. Halbert DN, Cutt JR, Shenk T. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host protein cell shutoff. J Virol 1985; 56: 250-257.
13. Boulanger P, Lemay P, Blair GE, Russell WC. Characterization of adenovirus protein IX. J Gen Virol 1979; 44: 783-800.
14. Rosenfeld MA, Yoshimura K, Trapnell BC et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68: 143-155.
15. Zabner J, Couture LA, Gregory RJ et al. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 1993; 75: 207-216.
16. Crystal RG, McElvaney NG, Rosenfeld MA et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 1994; 8: 42-51.
17. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59-72.
18. Lochmuller H, Jani A, Huard J et al. Emergence of early region-1 containing replication competent adenovirus in stocks of replication defective adenovirus recombinants (ΔE1 + ΔE3) during multiple passages in 293 cells. Hum Gene Ther 1994; 5: 1485-1493.
19. Berkner KL, Sharp PA. Generation of adenovirus by transfection of plasmids. Nucleic Acids Res 1983; 11: 6003-6020.
20. Hanahan D, Gluzman Y. Rescue of functional replication origins from embedded configurations in a plasmid carrying the adenovirus genome. Mol Cell Biol 1984; 4: 302-309.
21. Galiimore PH, Grand RJA, Byrd PJ. Transformation of human embryo retinoblasts with simian virus 40, adenovirus and ras oncogenes. Anticancer Res 1986; 6: 499-508.
22. Adra CN, Boer PH, McBurney MW. Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter. Gene 1987; 60: 65-74.
23. Vara JA, Portela A, Ortin J, Jimenez A. Expression in mammalian cells of a gene from Streptomyces alboniger conferring puromycin resistance. Nucleic Acids Res 1986; 14: 4617-4624.
24. Boeuf H, Jansen-Durr P, Kedinger C. E1A mediated trans-activation of the adenovirus E2A early promoter is restricted in undifferentiated F9 cells. Oncogene 1990; 5: 691-699.
25. Webster N, Jin JR, Green S et al. The yeast UASg is a transcriptional enhancer in human HeLa cells in the presence of the Ga14 trans-activator. Cell 1988; 52: 169-178.
26. Hitt MM, Graham FL. Adenovirus E1A under the control of heterologous promoters: wide variation in E1A expresssion levels has little effect on virus replication. Virology 1990; 179: 667-678.
27. Ghosh-Choudhury G, Haj-Ahmad Y, Graham FL. Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes. EMBO J 1987; 6: 1733-1739.
28. Fisher PB, Babiss LE, Weinstein IB, Ginsberg HS. Analysis of type 5 adenovirus transformation with a cloned rat embryo cell line (CREF). Proc Natl Acad Sci USA 1982; 79: 3527-3531.
29. Grodzicker T, Klessig DF. Expression of unselected adenovirus genes in human cells co-transformed with the HSV-1 TK gene and adenovirus 2 DNA. Cell 1980; 21: 453-463.
30. Babiss LE, Young CSH, Fisher PB, Ginsberg HS. Expression of adenovirus E1A and E1B gene products and the Escherichia coli XGPRT gene in KB cells. J Virol 1983; 46: 454-465.
31. Shiroki K, Saito I, Maruyama K et al. Expression of adenovirus type 12 early region 1 in KB cells transformed by recombinants containing the gene. J Virol 1983; 45: 1074-1082.
32. Simuzu B, Terasima T (eds). Vero cells: origin, properties and biomedical applications. The 25th anniversary of the establishment. Department of Microbiology, School of Medicine, University of Chiba: Chiba, 1987
33. Weinberg DH, Ketner G. A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2. Proc Natl Acad Sci USA 1983; 80: 5383-5386.
34. Smith CD, Craft DW, Shiromoto RS, Yan PO. Alternative cell line for virus isolation. J Clin Microbiol 1986; 24: 265-268.
35. Tacket CO, Losonsky G, Lubeck MD et al. Initial safety and immunogenicity studies of an oral adenohepatitis B vaccine. Vaccine 1992; 10: 673-676.
36. Klessig DF, Quinlan MP, Grodzicker T. Proteins containing only half of the coding information of early region 1b of adenovirus are functional in human cells transformed with the herpes simplex virus type I thymidine kinase gene and adenovirus type 2 DNA. J Virol 1982; 41: 423-434.
37. Babiss LE, Vales LD. Promoter of the adenovirus polypeptide IX gene: similarity to E1B and inactivation by substitution of the simian virus 40 TATA element. J Virol 1991; 65: 598-605.
38. Vales L, Darnell JE. Promoter occlusion prevents transcription of adenovirus polypeptide IX mRNA until after DNA replication. Genes Devel 1989; 3: 49-59.
39. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. BioTechnology 1989; 7: 980-990.
40. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titer retroviral vectors with multiple drug selection markers and a complementary helper free packaging cell line. Nucleic Acids Res 1990; 18: 3587-3596.
41. Lathe R, Vilotte JL, Clark AJ. Plasmid and bacteriophage vector for excision of intact inserts. Gene 1987; 57: 193-201.
42. Karasuyama H, Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin-2, -3, -4 or -5, using modified cDNA expression vectors. Eur J Immunol 1988; 18: 97-104.
43. Imler JL, Bout A, Dreyer D et al. Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses. Hum Gene Ther 1995; 6: 711-721.
44. Levrero M, Barban V, Manteca S et al. Defective and non-defective adenovirus vectors for expressing foreign genes in vitro and in vivo. Gene 1991; 101. 195-202.
45. Gray PW, Lung DW, Pennica D et al. Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 1982; 295: 503-508.
46. Leissner P, Calenda V, Marigliano M et al. In vitro and in vivo inhibition of HTV1 replication in human cells by transfer of HIV1-inducible human α, β and γ IFN genes (Submitted for publication).
47. Imler JL, Chartier C, Dieterle A et al. An efficient procedure to select and recover recombinant adenovirus vectors. Gene Therapy 1995; 2: 263-268.
48. Harlow E, Franza BR, Schley C. Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. J Virol 1985; 55: 533-546.